Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gynecology

  Free Subscription


16.09.2019

6 Acta Obstet Gynecol Scand
4 Am J Obstet Gynecol
1 Am J Surg Pathol
6 Anticancer Res
3 Aust N Z J Obstet Gynaecol
4 BMJ
3 Cancer
1 Cancer Lett
2 Eur J Obstet Gynecol Reprod Biol
13 Gynecol Oncol
1 Hum Reprod
3 Int J Cancer
5 Int J Gynaecol Obstet
6 J Clin Endocrinol Metab
3 J Clin Oncol
2 Lancet
1 Lancet HIV
1 Lancet Oncol
2 Lancet Public Health
16 Obstet Gynecol
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. MATSUBARA S, Takahashi H, Horie H, Kawada M, et al
    Preventing intrauterine balloon from descending: Some suggestions.
    Acta Obstet Gynecol Scand. 2019 Sep 13. doi: 10.1111/aogs.13728.
    PubMed     Text format     Abstract available

  2. MARASCHINI A, Lega I, D'Aloja P, Buoncristiano M, et al
    Women undergoing peripartum hysterectomy due to obstetric hemorrhage: a prospective population based study.
    Acta Obstet Gynecol Scand. 2019 Sep 13. doi: 10.1111/aogs.13727.
    PubMed     Text format     Abstract available

  3. DAWES LK, Prentice LR, Huang Y, Groom KM, et al
    The Biomarkers for Preterm Birth Study - A prospective observational study comparing the impact of vaginal biomarkers on clinical practice when used in women with symptoms of preterm labor.
    Acta Obstet Gynecol Scand. 2019 Sep 13. doi: 10.1111/aogs.13729.
    PubMed     Text format     Abstract available

  4. MAZARICO E, Molinet-Coll C, Jafet Martinez-Portilla R, Figueras F, et al
    Heparin therapy in placental insufficiency: systematic review and meta-analysis.
    Acta Obstet Gynecol Scand. 2019 Sep 13. doi: 10.1111/aogs.13730.
    PubMed     Text format     Abstract available

  5. HOCHLER H, Wainstock T, Lipschuetz M, Sheiner E, et al
    Grandmultiparity, maternal age, and the risk for uterine rupture - A multi-center cohort study.
    Acta Obstet Gynecol Scand. 2019 Sep 10. doi: 10.1111/aogs.13725.
    PubMed     Text format     Abstract available

  6. SPONHOLTZ SE, Mogensen O, Hildebrandt MG, Jensen PT, et al
    Clinical impact of pre-treatment FDG-PET/CT staging of primary ovarian-, fallopian tube- and peritoneal cancer in women.
    Acta Obstet Gynecol Scand. 2019 Sep 10. doi: 10.1111/aogs.13726.
    PubMed     Text format     Abstract available


    Am J Obstet Gynecol

  7. CHAEMSAITHONG P, Cuenca-Gomez D, Plana MN, Gil MM, et al
    Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
    Am J Obstet Gynecol. 2019 Sep 5. pii: S0002-9378(19)31062.
    PubMed     Text format     Abstract available

  8. RIZZOLO A, Shah PS, Boucorian I, Lemyre B, et al
    Cumulative effect of evidence-based practices on outcomes of preterm infants born at <29 weeks gestational age.
    Am J Obstet Gynecol. 2019 Sep 6. pii: S0002-9378(19)31105.
    PubMed     Text format     Abstract available

  9. BARTON JR, Woelkers DA, Newman RB, Combs CA, et al
    Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
    Am J Obstet Gynecol. 2019 Sep 10. pii: S0002-9378(19)31108.
    PubMed     Text format     Abstract available

  10. CHAM S, Wen T, Friedman A, Wright JD, et al
    Fragmentation of postoperative care after surgical management of ovarian cancer at 30-days and 90-days.
    Am J Obstet Gynecol. 2019 Sep 11. pii: S0002-9378(19)31110.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  11. LESKELA S, Romero I, Cristobal E, Perez-Mies B, et al
    The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group For Ovarian Cancer Research (GEICO).
    Am J Surg Pathol. 2019 Sep 6. doi: 10.1097/PAS.0000000000001365.
    PubMed     Text format     Abstract available


    Anticancer Res

  12. NASIOUDIS D, Wilson E, Mastroyannis SA, Sisti G, et al
    Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors.
    Anticancer Res. 2019;39:4971-4975.
    PubMed     Text format     Abstract available

  13. SLETTEN ET, Arnes M, Vereide AB, Orbo A, et al
    Intrauterine Progestin Therapy as a New Approach to Premalignant Endometrial Polyps: A Prospective Observational Study.
    Anticancer Res. 2019;39:4897-4903.
    PubMed     Text format     Abstract available

  14. TAMARI K, Sano K, Li Z, Seo Y, et al
    Ro 90-7501 Is a Novel Radiosensitizer for Cervical Cancer Cells that Inhibits ATM Phosphorylation.
    Anticancer Res. 2019;39:4805-4810.
    PubMed     Text format     Abstract available

  15. KIM Y, Kim YS, Kim M, Kim JM, et al
    Thioredoxin-interacting Protein (TXNIP) Mediates Thioredoxin-dependent Antioxidant Mechanism in Endometrial Cancer Cells Treated With 1alpha,25-dihydroxyvitamin D3.
    Anticancer Res. 2019;39:4795-4803.
    PubMed     Text format     Abstract available

  16. KOSCIELNY A, Ko A, Egger EK, Kuhn W, et al
    Prevention of Anastomotic Leakage in Ovarian Cancer Debulking Surgery and Its Impact on Overall Survival.
    Anticancer Res. 2019;39:5209-5218.
    PubMed     Text format     Abstract available

  17. YASUDA M, Kishimoto S, Amano M, Fukushima S, et al
    Comparison of Pregnane X Receptor Antagonists for Enhancing the Antitumor Effect of Cisplatin.
    Anticancer Res. 2019;39:4749-4755.
    PubMed     Text format     Abstract available


    Aust N Z J Obstet Gynaecol

  18. COSTELLO MF, Misso ML, Balen A, Boyle J, et al
    A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome.
    Aust N Z J Obstet Gynaecol. 2019 Sep 12. doi: 10.1111/ajo.13051.
    PubMed     Text format     Abstract available

  19. WANG M, Kirby A, Gibbs E, Gidaszewski B, et al
    Risk of preterm birth in the subsequent pregnancy following caesarean section at full cervical dilatation compared with mid-cavity instrumental delivery.
    Aust N Z J Obstet Gynaecol. 2019 Sep 12. doi: 10.1111/ajo.13058.
    PubMed     Text format     Abstract available

  20. HENRY C, Filoche S, Thunders M, Kenwright D, et al
    Reflection on the current status of endometrial cancer in New Zealand.
    Aust N Z J Obstet Gynaecol. 2019 Sep 12. doi: 10.1111/ajo.13057.
    PubMed     Text format     Abstract available


    BMJ

  21. ADHIKARI R
    US "global gag rule" on abortion is limiting family planning choices for women in Nepal.
    BMJ. 2019;366:l5354.
    PubMed     Text format    

  22. SCHULTEN SFM, Detollenaere RJ, Stekelenburg J, IntHout J, et al
    Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse stage 2 or higher: observational follow-up of a multicentre randomised trial.
    BMJ. 2019;366:l5149.
    PubMed     Text format     Abstract available

  23. WEBSTER K, Fishburn S, Maresh M, Findlay SC, et al
    Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance.
    BMJ. 2019;366:l5119.
    PubMed     Text format    

  24. DYER O
    Dutch physician sues FDA for blocking her abortion services in United States.
    BMJ. 2019;366:l5511.
    PubMed     Text format    


    Cancer

  25. PRINTZ C
    Cervical cancer subtype less detectable by Papanicolaou testing.
    Cancer. 2019;125:3287.
    PubMed     Text format    

  26. EL-JAWAHRI A, Fishman SR, Vanderklish J, Dizon DS, et al
    Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.
    Cancer. 2018 Mar 14. doi: 10.1002/cncr.31333.
    PubMed     Text format     Abstract available

  27. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
    Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
    Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
    PubMed     Text format     Abstract available


    Cancer Lett

  28. FENG S, Liu W, Bai X, Pan W, et al
    LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
    Cancer Lett. 2019;465:105-117.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  29. LAVIE M, Lavie I, Maslovitz S
    Paleolithic diet during pregnancy-A potential beneficial effect on metabolic indices and birth weight.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:7-11.
    PubMed     Text format     Abstract available

  30. DE MOREUIL C, Moineau MP, Padelli M, Lede F, et al
    First trimester serum biomarkers in pregnancies complicated with placental chronic inflammation.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:119-125.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  31. GRONWALD J, Lubinski J, Huzarski T, Cybulski C, et al
    A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.
    Gynecol Oncol. 2019 Sep 6. pii: S0090-8258(19)31486.
    PubMed     Text format     Abstract available

  32. MICHELS KA, McNeel TS, Trabert B
    Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data.
    Gynecol Oncol. 2019 Sep 5. pii: S0090-8258(19)31484.
    PubMed     Text format     Abstract available

  33. HOLLIS RL, Stanley B, Iida Y, Thomson J, et al
    Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma.
    Gynecol Oncol. 2019 Sep 5. pii: S0090-8258(19)31487.
    PubMed     Text format     Abstract available

  34. JOHANSEN G, Dahm-Kahler P, Staf C, Floter Radestad A, et al
    Fertility-sparing surgery for treatment of non-epithelial ovarian cancer: Oncological and reproductive outcomes in a prospective nationwide population-based cohort study.
    Gynecol Oncol. 2019 Sep 4. pii: S0090-8258(19)31469.
    PubMed     Text format     Abstract available

  35. MAKII C, Ikeda Y, Oda K, Uehara Y, et al
    Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma.
    Gynecol Oncol. 2019 Sep 4. pii: S0090-8258(19)31480.
    PubMed     Text format     Abstract available

  36. SIMS TT, Colbert LE, Zheng J, Delgado Medrano AY, et al
    Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
    Gynecol Oncol. 2019 Sep 6. pii: S0090-8258(19)31489.
    PubMed     Text format     Abstract available

  37. OLAWAIYE AB, Leath CA 3rd
    Contemporary management of uterine clear cell carcinoma: A Society of Gynecologic Oncology (SGO) review and recommendation.
    Gynecol Oncol. 2019 Sep 6. pii: S0090-8258(19)31483.
    PubMed     Text format     Abstract available

  38. SWAILES A, Gupta M, Chauhan SP, Kesterson J, et al
    Factors associated with the successful completion of randomized controlled trials in gynecological oncology.
    Gynecol Oncol. 2019 Sep 10. pii: S0090-8258(19)31527.
    PubMed     Text format     Abstract available

  39. SCHLECHTWEG K, Chen L, St Clair CM, Tergas AI, et al
    Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes.
    Gynecol Oncol. 2019 Sep 10. pii: S0090-8258(19)31522.
    PubMed     Text format     Abstract available

  40. VERGOTE I, du Bois A, Floquet A, Rau J, et al
    Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.
    Gynecol Oncol. 2019 Sep 10. pii: S0090-8258(19)31476.
    PubMed     Text format     Abstract available

  41. HIMOTO Y, Cybulska P, Shitano F, Sala E, et al
    Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?
    Gynecol Oncol. 2019 Sep 11. pii: S0090-8258(19)31462.
    PubMed     Text format     Abstract available

  42. DOCKERY LE, Rubenstein AR, Ding K, Mashburn SG, et al
    Extending the platinum-free interval: The impact of omitting 2nd line platinum chemotherapy in intermediate platinum-sensitive ovarian cancer.
    Gynecol Oncol. 2019 Sep 12. pii: S0090-8258(19)31394.
    PubMed     Text format     Abstract available

  43. WONG JWH, Killeen JL, Carney ME
    Completeness of salpingectomy intended for ovarian cancer risk reduction.
    Gynecol Oncol. 2019 Sep 12. pii: S0090-8258(19)31523.
    PubMed     Text format     Abstract available


    Hum Reprod

  44. PERSSON S, Elenis E, Turkmen S, Kramer MS, et al
    Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study.
    Hum Reprod. 2019 Sep 4. pii: 5556931. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Cancer

  45. LYU T, Jiang Y, Jia N, Che X, et al
    SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Int J Cancer. 2019 Sep 10. doi: 10.1002/ijc.32673.
    PubMed     Text format     Abstract available

  46. LINK T, Passek S, Wimberger P, Frank K, et al
    Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer.
    Int J Cancer. 2019 Sep 11. doi: 10.1002/ijc.32676.
    PubMed     Text format     Abstract available

  47. REIJNEN C, van der Putten LJM, Bulten J, Snijders MPLM, et al
    Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: a prospective multicentre cohort study.
    Int J Cancer. 2019 Sep 15. doi: 10.1002/ijc.32686.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  48. KIEMTORE S, Zoungrana Z, Zamane H, Kabore CWPD, et al
    Interventions to improve the use of long-acting reversible contraceptive methods at primary health centers in Burkina Faso.
    Int J Gynaecol Obstet. 2019 Sep 15. doi: 10.1002/ijgo.12973.
    PubMed     Text format     Abstract available

  49. YU Q, Ou H
    Efficacy of aspirin, prednisone, and multivitamin triple therapy in treating unexplained recurrent spontaneous abortion: a cohort study.
    Int J Gynaecol Obstet. 2019 Sep 15. doi: 10.1002/ijgo.12972.
    PubMed     Text format     Abstract available

  50. DE SILVA M, Panisi L, Brownfoot FC, Lindquist A, et al
    Systematic review of areca (betel nut) use and adverse pregnancy outcomes.
    Int J Gynaecol Obstet. 2019 Sep 13. doi: 10.1002/ijgo.12971.
    PubMed     Text format     Abstract available

  51. DAKHLY DMR, Gaafar HM, Sediek MM, Ibrahim MF, et al
    Diagnostic value of the International Ovarian Tumor Analysis (IOTA) simple rules versus pattern recognition to differentiate between malignant and benign ovarian masses.
    Int J Gynaecol Obstet. 2019 Sep 13. doi: 10.1002/ijgo.12970.
    PubMed     Text format     Abstract available

  52. WEI J, Zhou L
    Diagnostic ambiguity of a uterine fibroid with abnormal appearance after severe red degeneration: A case report.
    Int J Gynaecol Obstet. 2019 Sep 9. doi: 10.1002/ijgo.12965.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  53. OKEIGWE I, Bulun S, Liu S, Rademaker AW, et al
    PLIN2 Functions as a Novel Link between Progesterone Signaling and Metabolism in Uterine Leiomyoma Cells.
    J Clin Endocrinol Metab. 2019 Jul 23. pii: 5536619. doi: 10.1210/jc.2019-00762.
    PubMed     Text format     Abstract available

  54. CHOU CH, Chen SU, Chen CD, Shun CT, et al
    Mitochondrial dysfunction induced by high estradiol concentrations in endometrial epithelial cells.
    J Clin Endocrinol Metab. 2019 Sep 12. pii: 5568122. doi: 10.1210.
    PubMed     Text format     Abstract available

  55. KASVANDIK S, Saarma M, Kaart T, Rooda I, et al
    Uterine fluid proteins for minimally invasive assessment of endometrial receptivity.
    J Clin Endocrinol Metab. 2019 Sep 12. pii: 5568093. doi: 10.1210.
    PubMed     Text format     Abstract available

  56. KASVANDIK S, Saarma M, Kaart T, Rooda I, et al
    Uterine fluid proteins for minimally invasive assessment of endometrial receptivity.
    J Clin Endocrinol Metab. 2019 Sep 12. pii: 5568105. doi: 10.1210.
    PubMed     Text format     Abstract available

  57. KASVANDIK S, Saarma M, Kaart T, Rooda I, et al
    Uterine fluid proteins for minimally invasive assessment of endometrial receptivity.
    J Clin Endocrinol Metab. 2019 Sep 12. pii: 5568227. doi: 10.1210.
    PubMed     Text format     Abstract available

  58. CHOU CH, Chen SU, Chen CD, Shun CT, et al
    Mitochondrial dysfunction induced by high estradiol concentrations in endometrial epithelial cells.
    J Clin Endocrinol Metab. 2019 Sep 12. pii: 5568229. doi: 10.1210.
    PubMed     Text format     Abstract available


    J Clin Oncol

  59. GUPTA VG, Goel V
    Differences Between Chemotherapy-Resistant Disease and Inoperable Disease in Cervical Cancer Treated With Neoadjuvant Chemotherapy.
    J Clin Oncol. 2018 Jun 13:JCO2018786632. doi: 10.1200/JCO.2018.78.6632.
    PubMed     Text format    

  60. SHIN DW, Lee JW, Jung JH, Han K, et al
    Disparities in Cervical Cancer Screening Among Women With Disabilities: A National Database Study in South Korea.
    J Clin Oncol. 2018 Aug 3:JCO2018777912. doi: 10.1200/JCO.2018.77.7912.
    PubMed     Text format     Abstract available

  61. ZOU W, Hu C, Feng Y, Wang J, et al
    Treatment Protocols for Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer.
    J Clin Oncol. 2018 Jun 13:JCO2018788893. doi: 10.1200/JCO.2018.78.8893.
    PubMed     Text format    


    Lancet

  62. COOPER K, Breeman S, Scott NW, Scotland G, et al
    Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)31790.
    PubMed     Text format     Abstract available

  63. SINGH S, Bougie O
    HEALTH for heavy menstrual bleeding: real-world implications.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)32086.
    PubMed     Text format    


    Lancet HIV

  64. SCARSI KK, Cramer YS, Rosenkranz SL, Aweeka F, et al
    Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study.
    Lancet HIV. 2019;6:e601-e612.
    PubMed     Text format     Abstract available


    Lancet Oncol

  65. GIULIANO M, Schettini F, Rognoni C, Milani M, et al
    Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
    Lancet Oncol. 2019 Sep 4. pii: S1470-2045(19)30420.
    PubMed     Text format     Abstract available


    Lancet Public Health

  66. XIA C, Hu S, Xu X, Zhao X, et al
    Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study.
    Lancet Public Health. 2019;4:e462-e472.
    PubMed     Text format     Abstract available

  67. MALAGON T
    Reasons for optimism about eliminating cervical cancer in China.
    Lancet Public Health. 2019;4:e434-e435.
    PubMed     Text format    


    Obstet Gynecol

  68. VILKINS AL, Sahara M, Till SR, Ceci C, et al
    Effects of Shared Decision Making on Opioid Prescribing After Hysterectomy.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003468.
    PubMed     Text format     Abstract available

  69. FOX NS, Oster EF
    The Advice We Give to Pregnant Women: Sleep On It.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003466.
    PubMed     Text format    

  70. SMITH GN, Louis JM, Saade GR
    Pregnancy and the Postpartum Period as an Opportunity for Cardiovascular Risk Identification and Management.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003363.
    PubMed     Text format     Abstract available

  71. WHITESIDE JL
    What Is New in Recovery After Gynecologic Surgery for Benign Indications?: Best Articles From the Past Year.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003480.
    PubMed     Text format     Abstract available

  72. WHEELER LJ, Desanto K, Teal SB, Sheeder J, et al
    Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003463.
    PubMed     Text format     Abstract available

  73. KERNS JL, Ti A, Aksel S, Lederle L, et al
    Disseminated Intravascular Coagulation and Hemorrhage After Dilation and Evacuation Abortion for Fetal Death.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003460.
    PubMed     Text format     Abstract available

  74. CHERRY SB, Vasko M
    Proper Surgical Dressing Removal Technique in Obstetrics and Gynecology.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003469.
    PubMed     Text format     Abstract available

  75. LUCKETT R, Mogowa N, Li HJ, Erlinger A, et al
    Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003496.
    PubMed     Text format     Abstract available

  76. MORGAN HK, Graziano SC, Craig LB, Everett EN, et al
    A National Survey of Profiles of Clerkship Directors in Obstetrics and Gynecology.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003471.
    PubMed     Text format     Abstract available

  77. WESTERFIELD KL, Bhavsar AK, Green S
    Aspiration Pneumonitis Causing Respiratory Collapse in a Pregnant Patient Not in Labor.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003486.
    PubMed     Text format     Abstract available

  78. NEZHAT C, Vang N, Tanaka PP, Nezhat C, et al
    Optimal Management of Endometriosis and Pain.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003461.
    PubMed     Text format     Abstract available

  79. LAZORWITZ A, Aquilante CL, Dindinger E, Harrison M, et al
    Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003452.
    PubMed     Text format     Abstract available

  80. REILLY ZP, Fruhauf TF, Martin SJ
    Barriers to Evidence-Based Transgender Care: Knowledge Gaps in Gender-Affirming Hysterectomy and Oophorectomy.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003472.
    PubMed     Text format     Abstract available

  81. MATULICH MC, Chen MJ, Schimmoeller NR, Hsia JK, et al
    Referral Center Experience With Nonpalpable Contraceptive Implant Removals.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003457.
    PubMed     Text format     Abstract available

  82. SILVER RM, Hunter S, Reddy UM, Facco F, et al
    Prospective Evaluation of Maternal Sleep Position Through 30 Weeks of Gestation and Adverse Pregnancy Outcomes.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003458.
    PubMed     Text format     Abstract available

  83. NAERT MN, Muniz Rodriguez A, Khadraoui H, Naqvi M, et al
    Association Between First-Trimester Subchorionic Hematomas and Adverse Pregnancy Outcomes After 20 Weeks of Gestation in Singleton Pregnancies.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003487.
    PubMed     Text format     Abstract available


    Urology

  84. GRAHAM LS, Schade G, Schweizer MT
    Multimodality Treatment of Bilateral Wilms Tumor in a Pregnant Female.
    Urology. 2019 Sep 5. pii: S0090-4295(19)30794.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: